Cryoport Inc (CYRX) 2.88 $CYRX Cryoport Appoints Robert

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cryoport Inc (CYRX) 2.88 $CYRX

Cryoport Appoints Robert Hariri, MD, PhD to its Board of Directors
PR Newswire - Thu Oct 01, 7:00AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Company" today announced the appointment of Robert Hariri, MD, PhD to its Board of Directors.
CYRX: 2.88 (-0.03), MYOS: 3.41 (+0.15), CELG: 117.38 (-0.59), CELGZ: 1.74 (+0.04)

Cryoport Acquires Full IP Rights to Cryoportal(TM)
PR Newswire - Thu Sep 24, 8:56AM CDT
Cryoport, Inc. (NASDAQ:CYRX) ("Company" today announced the purchase of certain intellectual property and intellectual property rights to the Cryoportal(TM) operating platform from KLATU Networks, LLC ("Klatu".
FDX: 155.33 (-0.22), CYRX: 2.88 (-0.03)

Cryoport Supports Stemedica's Ischemic-Tolerant Stem Cell Product Lines
PR Newswire - Tue Aug 18, 7:30AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that its validated cryogenic logistics solution is supporting the worldwide distribution of Stemedica's ischemic-tolerant stem cell product lines.
CYRX: 2.88 (-0.03)

Cryoport Reports 53% Revenue Growth for the First Quarter of Fiscal Year 2016
PR Newswire - Thu Aug 06, 7:00AM CDT
Cryoport, Inc. (NASDAQ: CYRX) today announced financial results for the three-month period ended June 30, 2015.
CYRX: 2.88 (-0.03)

Cryoport to Report First Quarter Fiscal 2016 Financial Results
PR Newswire - Mon Aug 03, 7:30AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company will release financial results for the first quarter fiscal year 2016 ended June 30, 2015 on Thursday, August 6 before the market opens.
CYRX: 2.88 (-0.03)

Cryoport Provides Cryogenic Logistics Solutions to HemaCare Corporation
PR Newswire - Thu Jul 30, 7:30AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company will provide cryogenic logistics solutions to HemaCare Corporation ("HemaCare", a leading global provider of high-quality biological material to the scientific community.
CYRX: 2.88 (-0.03)

Cryoport Completes $6.8 Million Equity Capital Raise
PR Newswire - Wed Jul 29, 12:30PM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, announced today that the Company has completed the sale of common stock and warrants (the "Units" under a registered public offering. The gross proceeds to Cryoport from the offering, including the partial exercise of the over-allotment option, were approximately $6.8 million, before underwriting discounts and commissions and other offering expenses.
CYRX: 2.88 (-0.03)

Cryoport's Portfolio of Temperature-Managed Clinical Programs Expands to 45 Trials
PR Newswire - Mon Jul 27, 7:30AM CDT
Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport" or the "Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, with markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, is now supporting approximately 45 clinical trials. The majority of these trials are regenerative therapies, including an array of CAR T-cell therapies. In total, these immunotherapy trials are expected to contribute as much as $150 million of revenue for Cryoport over the next five years.
CYRX: 2.88 (-0.03)

Cryoport Announces Pricing of Public Offering of Units and Listing on NASDAQ
PR Newswire - Thu Jul 23, 7:41PM CDT
Cryoport, Inc. (NASDAQ: CYRX, CYRXW) ("Cryoport" or the "Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced the pricing of an underwritten public offering of 2,000,000 units at an offering price of $3.25 per unit, with each unit consisting of one share of common stock and one warrant to purchase one share of common stock. The common stock and the warrants are immediately separable, and will trade on The Nasdaq Capital Market under the symbols CYRX, and CYRXW, respectively. The warrants will have a per share exercise price of $3.57, are exercisable immediately and will expire five years from the date of issuance.
CYRX: 2.88 (-0.03)

ZenBio Engages Cryoport to Support Distribution of its Human Cell-Based Products
PR Newswire - Tue Jul 14, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Cryoport" or the "Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company's validated cryogenic logistics solution is supporting ZenBio Inc. ("ZenBio" in the distribution of its Human Platelet Lysate as well as its entire array of cell-based solutions for the discovery and development of regenerative therapies.
CYRX: 2.88 (-0.03)

Cryoport Selected for Logistics Support of CaRE Arthritis Personalized Medicine Efforts
PR Newswire - Wed Jun 17, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company is the preferred cryogenic logistics provider to CaRE Arthritis ("CaRE".
CYRX: 2.88 (-0.03)

Cryoport: A Niche Player That Doesn't Know It
Gains on Gains - at Seeking Alpha - Mon Jun 15, 3:00PM CDT

CYRX: 2.88 (-0.03)

Cryoport Selected by Lynden International as the Preferred Cryogenic Logistics Provider
PR Newswire - Wed Jun 10, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that it has been selected by Lynden International ("Lynden" as its preferred provider to support cold chain clinical trial logistics for underrepresented diseases in Africa.
CYRX: 2.88 (-0.03)

Cryoport Supports ArunA Biomedical's Cryogenic Shipments of Stem Cell Kits
PR Newswire - Wed Jun 03, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal health, and reproductive medicine, today announced that the Company is supporting ArunA Biomedical's ("ArunA" cryogenic shipments of stem cell kits.
CYRX: 2.88 (-0.03)

Cryoport achieves record revenue rise of 48% for fiscal 2015
M2 - Wed May 20, 6:25AM CDT
Cryogenic logistics company Cryoport (OTCBB:CYRX) disclosed on Tuesday that it recorded a net loss of USD12.2m (USD2.44 per common share) for the 12 month periods ended 31 March 2015.
CYRX: 2.88 (-0.03)

Cryoport Reports Record Revenues For Fourth Quarter and Fiscal Year 2015
PR Newswire - Tue May 19, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) today announced financial results for the three and twelve-month periods ended March 31, 2015.
CYRX: 2.88 (-0.03)

Cryoport to Present its FY2015 Results and Business Update at the 2015 Marcum MicroCap Conference
PR Newswire - Thu May 07, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers, animal husbandry and reproductive medicine, announced today that its Chief Executive Officer, Jerrell Shelton, is scheduled to present at the 2015 Marcum MicroCap Conference at the Grand Hyatt in New York City on Thursday, May 28, 2015 at 9:30 a.m. EDT.
CYRX: 2.88 (-0.03)

Cryoport Supports NeoStem's Intus Study for the Treatment of Metastatic Melanoma
PR Newswire - Wed Apr 29, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that the Company is supporting NeoStem, Inc.'s (NASDAQ: NBS) Intus Study to evaluate its lead cancer immunotherapy, NBS20, for the treatment of metastatic melanoma.
CYRX: 2.88 (-0.03), NBS: 2.25 (-0.09)

Cryoport to Support the Equine Animal Husbandry Market Through Agreement with Yancey Farms
PR Newswire - Thu Apr 23, 8:15AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, today announced that the Company has further established its cryogenic logistics solutions within the animal husbandry market by signing a new customer agreement with Yancey Farms to support the shipment of equine semen for artificial insemination of top German Sport horse Stallions.
CYRX: 2.88 (-0.03)

Cryoport to Present at the 3rd Annual BioLogistics Summit in San Francisco, CA
PR Newswire - Tue Apr 21, 7:30AM CDT
Cryoport, Inc. (OTCBB: CYRX) ("Company", the leading provider of advanced cryogenic logistics solutions for the life sciences industry, serving markets including immunotherapies, stem cells, cell lines, clinical research organizations, vaccine manufacturers and reproductive medicine, today announced that Dr. Mark W. Sawicki, Chief Commercial Officer, will present at the 3rd Annual BioLogistics Summit in San Francisco, CA on Wednesday, July 15th, 2015, at 2:15 p.m. PT. Dr. Sawicki will discuss advanced logistics for both clinical samples and commercial finished goods of emerging cell and gene therapies.
CYRX: 2.88 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Keiki Smiles Boosts Pediatric Dental Care in Waipahu

Updated Category News Views 55

A Neighborhood Dentists' Big Move: Keiki Smiles Expands in Waipahu Well, if there's one thing the dentists of Waipahu know how to do, it's adapt and grow. Keiki Smiles of Leeward, a trusted name in pediatric dentistry, just set up shop at a fresh location. The move marks a new chapter for this community staple, and honestly, it's miles more than just a longer lease and a...

Continue Reading
Better Life Science: Revolutionizing At-Home STI Testing

Updated Category News Views 98

Paving a New Path for STI Testing Accessibility The landscape of STI testing is undergoing a significant shift, and Better Life Science is at the helm with their innovative STD Hero at-home testing service. With a splash in the latest AVN report, they're turning heads in both the clinical world and in mainstream society. This ain't just about checking boxes in health...

Continue Reading
IQSTEL's Nine-Month Revenue Hits $313M, Growth Impresses

Updated Category News Views 41

Pushing Through With Persistence Well, well, well, here we are, talking about IQSTEL Inc. (NASDAQ: IQST) slinging some serious numbers—not the kind you can ignore at your breakfast table. The company pulled in a whopping $313 million in revenue over the first nine months of 2026. That’s a bump up by 34.5% from last year’s $232.7 million. What’s behind the magic...

Continue Reading
Local Bounti Expands: Acquires CEA Facilities

Updated Category News Views 37

Local Bounti's Strategic Acquisition Move Local Bounti's at it again, shaking up the indoor agriculture scene by snapping up some real estate from Revol Greens. We're talking 30 acres of primo certified-organic greenhouse space across Texas and Minnesota. And they’re picking these babies up right as they’re ready to grow, not like some flashy land grab. Digging into...

Continue Reading
WirelessCar Rebrands to Reinforce Connected Mobility Vision

Updated Category News Views 97

Evolving Identity for Changing Times Let’s dive right into it—WirelessCar, a name that’s struck chords in the automotive trenches for ages, is taking a bold step by unveiling a new brand identity. Now, don’t roll your eyes just yet. This isn’t another company tapping the rebranding siren for the heck of it. We’re talking about a company that’s been in the...

Continue Reading
Surgical Tooth Extraction: When It’s Necessary

Updated Category News Views 42

Unpacking the Complexities of Tooth Extraction Ever wonder why some tooth extractions are a stroll in the park while others dive straight into surgical territory? It's all about positioning, condition, and what's lurking underneath. Thanks to Dr. Yadira Cardona-Rohena of Hamilton Mill Oral & Facial Surgery, we’ve got the lowdown. The Need for Skilled Surgical Techniques...

Continue Reading
Epic Legal Battle Yields $63M Verdict Against Chevron

Updated Category News Views 31

A David vs. Goliath Showdown in Court How's this for a courtroom drama? Picture eight lawyers taking on Chevron over a toxic pit buried beneath an unsuspecting family's home. These folks at Ernst Law Group and Trial Lawyers for Justice tackled Union Oil (now Chevron) and bagged a staggering $63 million for their client. This ain't your run-of-the-mill legal squabble; it's...

Continue Reading
Sulzer Rebuilds Petrocedeño Tower: A Milestone in Oil Revival

Updated Category News Views 223

Venezuela's Oil Infrastructure Gets a Crucial Boost No one said reviving a near-busted oil facility in Venezuela would be a walk in the park. But that's just what North American Blue Energy Partners (NABEP) is doing, handing the reins to Sulzer to rebuild a busted crude tower at the Petrocedeño upgrader. This ain't just another run-of-the-mill repair job; this is the...

Continue Reading
Exploring Creation: A Fresh Look at Genesis

Updated Category News Views 32

Opening Up Genesis in a New Light Hey, if you’re like most folks, you’ve probably heard Genesis framed as the battleground for science versus religion debates, right? Enter into this mix a fresh take with Robert E. Franzen’s new book, The Narration of Creation. This book asks you to overlook those grand philosophical fights and instead focus on the narrative itself....

Continue Reading
Waterfall Backs $48M Loan for Disney-area Hotel Upgrade

Updated Category News Views 185

A $48 Million Shot in the Arm for Portofino Inn Old-school Anaheim just got a real estate shake-up. Waterfall Asset Management's decision to lend a hefty $48 million to Dynamic City Capital (DCC) is more than just a financial move—it's a bet on tourism's bedrock, Disneyland. They're sinking this cash into the Portofino Inn & Suites, located a stone's throw from the...

Continue Reading

Top 5 Most Recently Viewed Articles

Vizzy Hard Seltzer Unveils Exciting Cream Pop Variety Pack

Updated Category News Views 247

Vizzy Hard Seltzer Expands Flavor Options with New Variety Pack Vizzy Hard Seltzer is making waves by introducing its delightful Cream Pop Variety Pack, which marks a new chapter in its product line. This exciting pack is all set to enhance your sipping experience with flavors inspired by cherished childhood treats. Bringing together the well-loved Orange Cream Pop and...

Continue Reading
X-Bow Systems Expands DoD Partnership with New Funding Boost

Updated Category News Views 406

Significant Funding Boost for X-Bow Systems X-Bow Systems Inc. is making waves in the defense industry with its recent expansion of a crucial contract with the Department of Defense (DoD). This boost in funding follows a notable $64 million awarded in 2023 aimed at enhancing the production capacity of solid rocket motors. With this additional investment, X-Bow aims to...

Continue Reading
Digerati Technologies Mourns the Loss of Founding CEO Arthur Smith

Updated Category News Views 211

A Tribute to CEO Arthur L. Smith of Digerati Technologies Digerati Technologies, Inc. (OTC: DTGI), known for its dedicated approach to cloud services, recently lost its revered Founder and Chief Executive Officer, Arthur L. Smith. His passing has left a profound impact on the company, its employees, and the broader business community. Honoring a Visionary Leader Arthur L....

Continue Reading
Investors Encouraged to Engage in Transocean Ltd. Lawsuit

Updated Category News Views 142

Opportunity for Transocean Ltd. Investors Recent developments have opened a new chapter for investors of Transocean Ltd. (NYSE: RIG). Those who purchased securities between October 31, 2023, and September 2, 2024, referred to as the "Class Period," are now being called to action. This is a moment not just for individual investors, but a collective initiative to ensure...

Continue Reading
Blue Owl Capital Sets New Milestones with OWL Stock Growth

Updated Category News Views 144

Blue Owl Capital's Remarkable Stock Surge In a noteworthy display of market confidence, OWL stock has reached an impressive price level of $23.7, marking an all-time high. This significant milestone highlights the company's strong performance and the optimistic outlook investors have regarding its potential for growth. Over the last year, the company has experienced an...

Continue Reading